The elements contained in the promotional communication of the plasmas mentioned in article L. 1223-3 comply with the information contained in the corresponding part of the decision of the Director General of the Agence nationale de sécurité du médicament et des produits de santé mentioned in 1° of article L. 1221-8 and with the recommendations of the Haute Autorité de santé mentioned in article L. 1223-2.